Structure

Physi-Chem Properties

Molecular Weight:  430.27
Volume:  469.272
LogP:  3.499
LogD:  3.52
LogS:  -4.343
# Rotatable Bonds:  10
TPSA:  69.67
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.297
Synthetic Accessibility Score:  5.322
Fsp3:  0.654
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.668
MDCK Permeability:  2.431091525068041e-05
Pgp-inhibitor:  0.2
Pgp-substrate:  0.007
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.725
30% Bioavailability (F30%):  0.025

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.991
Plasma Protein Binding (PPB):  64.03158569335938%
Volume Distribution (VD):  2.231
Pgp-substrate:  36.48787307739258%

ADMET: Metabolism

CYP1A2-inhibitor:  0.015
CYP1A2-substrate:  0.122
CYP2C19-inhibitor:  0.031
CYP2C19-substrate:  0.594
CYP2C9-inhibitor:  0.025
CYP2C9-substrate:  0.035
CYP2D6-inhibitor:  0.027
CYP2D6-substrate:  0.125
CYP3A4-inhibitor:  0.911
CYP3A4-substrate:  0.674

ADMET: Excretion

Clearance (CL):  5.874
Half-life (T1/2):  0.195

ADMET: Toxicity

hERG Blockers:  0.46
Human Hepatotoxicity (H-HT):  0.289
Drug-inuced Liver Injury (DILI):  0.049
AMES Toxicity:  0.427
Rat Oral Acute Toxicity:  0.524
Maximum Recommended Daily Dose:  0.973
Skin Sensitization:  0.973
Carcinogencity:  0.394
Eye Corrosion:  0.802
Eye Irritation:  0.132
Respiratory Toxicity:  0.978

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470297

Natural Product ID:  NPC470297
Common Name*:   [(2R,4As,5S,7R,8R,8As)-4,4A-Diformyl-5-Methoxy-7,8-Dimethyl-8-[(2E)-3-Methylpenta-2,4-Dienyl]-1,2,5,6,7,8A-Hexahydronaphthalen-2-Yl] 2-Methylbutanoate
IUPAC Name:   [(2R,4aS,5S,7R,8R,8aS)-4,4a-diformyl-5-methoxy-7,8-dimethyl-8-[(2E)-3-methylpenta-2,4-dienyl]-1,2,5,6,7,8a-hexahydronaphthalen-2-yl] 2-methylbutanoate
Synonyms:  
Standard InCHIKey:  IIENMWMYMSMVQK-BDLHYKASSA-N
Standard InCHI:  InChI=1S/C26H38O5/c1-8-17(3)10-11-25(6)19(5)12-23(30-7)26(16-28)20(15-27)13-21(14-22(25)26)31-24(29)18(4)9-2/h8,10,13,15-16,18-19,21-23H,1,9,11-12,14H2,2-7H3/b17-10+/t18?,19-,21+,22+,23+,25-,26+/m1/s1
SMILES:  CCC(C)C(=O)OC1CC2C(C(CC(C2(C(=C1)C=O)C=O)OC)C)(C)CC=C(C)C=C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL194808
PubChem CID:   44404751
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1241 Laetia procera Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[16168652]
NPO1241 Laetia procera Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens Activity = 9.6 uM PMID[496471]
NPT83 Cell Line MCF7 Homo sapiens Ratio = 2.7 n.a. PMID[496471]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 6.04 uM PMID[496471]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 3.79 uM PMID[496471]
NPT634 Organism Leishmania amazonensis Leishmania amazonensis Activity = 30.3 uM PMID[496471]
NPT634 Organism Leishmania amazonensis Leishmania amazonensis Activity = 50.9 uM PMID[496471]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470297 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.95 High Similarity NPC89171
0.95 High Similarity NPC476802
0.9135 High Similarity NPC476801
0.8673 High Similarity NPC470697
0.8544 High Similarity NPC254202
0.8485 Intermediate Similarity NPC477130
0.8485 Intermediate Similarity NPC477129
0.8476 Intermediate Similarity NPC133422
0.8431 Intermediate Similarity NPC476933
0.8381 Intermediate Similarity NPC469607
0.8381 Intermediate Similarity NPC1679
0.83 Intermediate Similarity NPC38830
0.83 Intermediate Similarity NPC269729
0.8288 Intermediate Similarity NPC474518
0.8286 Intermediate Similarity NPC189616
0.8283 Intermediate Similarity NPC473944
0.8265 Intermediate Similarity NPC284561
0.8257 Intermediate Similarity NPC277769
0.8252 Intermediate Similarity NPC475385
0.8252 Intermediate Similarity NPC475392
0.8252 Intermediate Similarity NPC471413
0.8252 Intermediate Similarity NPC475202
0.8235 Intermediate Similarity NPC2049
0.8224 Intermediate Similarity NPC275539
0.8224 Intermediate Similarity NPC189075
0.8218 Intermediate Similarity NPC274417
0.82 Intermediate Similarity NPC475657
0.819 Intermediate Similarity NPC95585
0.819 Intermediate Similarity NPC282233
0.8182 Intermediate Similarity NPC152467
0.8182 Intermediate Similarity NPC56448
0.8182 Intermediate Similarity NPC471204
0.8173 Intermediate Similarity NPC471412
0.8155 Intermediate Similarity NPC23364
0.8148 Intermediate Similarity NPC474243
0.8148 Intermediate Similarity NPC112457
0.8144 Intermediate Similarity NPC220478
0.8137 Intermediate Similarity NPC151725
0.8137 Intermediate Similarity NPC106425
0.8137 Intermediate Similarity NPC122324
0.8131 Intermediate Similarity NPC110496
0.8125 Intermediate Similarity NPC476959
0.8108 Intermediate Similarity NPC238667
0.8095 Intermediate Similarity NPC469606
0.8095 Intermediate Similarity NPC162973
0.8095 Intermediate Similarity NPC31058
0.8095 Intermediate Similarity NPC273005
0.8091 Intermediate Similarity NPC269530
0.8091 Intermediate Similarity NPC4573
0.8091 Intermediate Similarity NPC90952
0.8081 Intermediate Similarity NPC73995
0.8077 Intermediate Similarity NPC174314
0.807 Intermediate Similarity NPC476962
0.8058 Intermediate Similarity NPC38530
0.8058 Intermediate Similarity NPC84335
0.8058 Intermediate Similarity NPC110937
0.8053 Intermediate Similarity NPC470420
0.8053 Intermediate Similarity NPC284707
0.8039 Intermediate Similarity NPC183012
0.8036 Intermediate Similarity NPC477509
0.8019 Intermediate Similarity NPC95899
0.8019 Intermediate Similarity NPC471365
0.8019 Intermediate Similarity NPC471364
0.8019 Intermediate Similarity NPC120321
0.8019 Intermediate Similarity NPC132395
0.8018 Intermediate Similarity NPC469454
0.8018 Intermediate Similarity NPC469463
0.8018 Intermediate Similarity NPC469496
0.8 Intermediate Similarity NPC469595
0.8 Intermediate Similarity NPC328141
0.8 Intermediate Similarity NPC310981
0.8 Intermediate Similarity NPC304180
0.8 Intermediate Similarity NPC212679
0.8 Intermediate Similarity NPC220454
0.8 Intermediate Similarity NPC159748
0.8 Intermediate Similarity NPC179798
0.8 Intermediate Similarity NPC101651
0.7982 Intermediate Similarity NPC469370
0.7982 Intermediate Similarity NPC475520
0.7981 Intermediate Similarity NPC264378
0.7981 Intermediate Similarity NPC471932
0.798 Intermediate Similarity NPC477128
0.798 Intermediate Similarity NPC215831
0.7965 Intermediate Similarity NPC98249
0.7965 Intermediate Similarity NPC134430
0.7965 Intermediate Similarity NPC53396
0.7963 Intermediate Similarity NPC476958
0.7963 Intermediate Similarity NPC179380
0.7961 Intermediate Similarity NPC118159
0.7961 Intermediate Similarity NPC29952
0.7944 Intermediate Similarity NPC118911
0.7941 Intermediate Similarity NPC471446
0.7941 Intermediate Similarity NPC474841
0.7941 Intermediate Similarity NPC473434
0.7941 Intermediate Similarity NPC250075
0.7928 Intermediate Similarity NPC12046
0.7928 Intermediate Similarity NPC265391
0.7928 Intermediate Similarity NPC194951
0.7925 Intermediate Similarity NPC475091
0.7917 Intermediate Similarity NPC470813
0.7909 Intermediate Similarity NPC253906
0.7909 Intermediate Similarity NPC478209
0.7905 Intermediate Similarity NPC470761
0.7905 Intermediate Similarity NPC35751
0.7905 Intermediate Similarity NPC474012
0.7905 Intermediate Similarity NPC476299
0.7905 Intermediate Similarity NPC470906
0.7905 Intermediate Similarity NPC473219
0.7905 Intermediate Similarity NPC54705
0.7895 Intermediate Similarity NPC21326
0.7895 Intermediate Similarity NPC473720
0.789 Intermediate Similarity NPC476479
0.7879 Intermediate Similarity NPC175293
0.7876 Intermediate Similarity NPC476963
0.787 Intermediate Similarity NPC478208
0.7863 Intermediate Similarity NPC55602
0.7857 Intermediate Similarity NPC25909
0.7857 Intermediate Similarity NPC470120
0.7857 Intermediate Similarity NPC157441
0.7857 Intermediate Similarity NPC159333
0.785 Intermediate Similarity NPC473283
0.785 Intermediate Similarity NPC475526
0.785 Intermediate Similarity NPC329345
0.7843 Intermediate Similarity NPC79117
0.7843 Intermediate Similarity NPC474185
0.7838 Intermediate Similarity NPC474315
0.7838 Intermediate Similarity NPC188738
0.7838 Intermediate Similarity NPC470960
0.783 Intermediate Similarity NPC168319
0.783 Intermediate Similarity NPC111292
0.783 Intermediate Similarity NPC472637
0.783 Intermediate Similarity NPC194028
0.783 Intermediate Similarity NPC476478
0.7826 Intermediate Similarity NPC476960
0.7826 Intermediate Similarity NPC473636
0.7826 Intermediate Similarity NPC77689
0.7822 Intermediate Similarity NPC469372
0.7822 Intermediate Similarity NPC474842
0.7822 Intermediate Similarity NPC475965
0.781 Intermediate Similarity NPC316598
0.781 Intermediate Similarity NPC176845
0.781 Intermediate Similarity NPC57079
0.781 Intermediate Similarity NPC216478
0.781 Intermediate Similarity NPC108368
0.7807 Intermediate Similarity NPC475809
0.7807 Intermediate Similarity NPC469684
0.7807 Intermediate Similarity NPC23046
0.78 Intermediate Similarity NPC473229
0.78 Intermediate Similarity NPC226863
0.7798 Intermediate Similarity NPC302788
0.7788 Intermediate Similarity NPC470953
0.7788 Intermediate Similarity NPC202833
0.7788 Intermediate Similarity NPC311166
0.7778 Intermediate Similarity NPC476001
0.7778 Intermediate Similarity NPC96268
0.7778 Intermediate Similarity NPC168248
0.7778 Intermediate Similarity NPC474898
0.7778 Intermediate Similarity NPC146731
0.7778 Intermediate Similarity NPC170538
0.7778 Intermediate Similarity NPC239162
0.7768 Intermediate Similarity NPC69291
0.7767 Intermediate Similarity NPC473435
0.7767 Intermediate Similarity NPC471078
0.7767 Intermediate Similarity NPC473280
0.7767 Intermediate Similarity NPC473431
0.7759 Intermediate Similarity NPC476961
0.7759 Intermediate Similarity NPC184555
0.7757 Intermediate Similarity NPC155332
0.7757 Intermediate Similarity NPC164551
0.7757 Intermediate Similarity NPC114540
0.7757 Intermediate Similarity NPC32577
0.7757 Intermediate Similarity NPC80781
0.7757 Intermediate Similarity NPC137430
0.7757 Intermediate Similarity NPC320447
0.7757 Intermediate Similarity NPC478156
0.7757 Intermediate Similarity NPC476081
0.7757 Intermediate Similarity NPC235369
0.7748 Intermediate Similarity NPC286880
0.7748 Intermediate Similarity NPC5103
0.7745 Intermediate Similarity NPC477574
0.7736 Intermediate Similarity NPC117685
0.7736 Intermediate Similarity NPC473204
0.7736 Intermediate Similarity NPC104861
0.7736 Intermediate Similarity NPC306856
0.7736 Intermediate Similarity NPC471041
0.7736 Intermediate Similarity NPC47024
0.7727 Intermediate Similarity NPC318363
0.7727 Intermediate Similarity NPC475418
0.7727 Intermediate Similarity NPC322903
0.7727 Intermediate Similarity NPC151393
0.7727 Intermediate Similarity NPC306265
0.7727 Intermediate Similarity NPC473482
0.7727 Intermediate Similarity NPC473483
0.7719 Intermediate Similarity NPC72772
0.7719 Intermediate Similarity NPC469794
0.7714 Intermediate Similarity NPC474343
0.7714 Intermediate Similarity NPC226986
0.7714 Intermediate Similarity NPC476768
0.7714 Intermediate Similarity NPC292133
0.7714 Intermediate Similarity NPC472188

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470297 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7677 Intermediate Similarity NPD1694 Approved
0.767 Intermediate Similarity NPD5778 Approved
0.767 Intermediate Similarity NPD5779 Approved
0.7477 Intermediate Similarity NPD7638 Approved
0.7429 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD7900 Approved
0.7407 Intermediate Similarity NPD7640 Approved
0.7407 Intermediate Similarity NPD7639 Approved
0.7404 Intermediate Similarity NPD6411 Approved
0.7387 Intermediate Similarity NPD6008 Approved
0.7374 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD3573 Approved
0.735 Intermediate Similarity NPD7115 Discovery
0.7315 Intermediate Similarity NPD4225 Approved
0.7222 Intermediate Similarity NPD7902 Approved
0.7212 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6101 Approved
0.7168 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD7748 Approved
0.7069 Intermediate Similarity NPD6650 Approved
0.7069 Intermediate Similarity NPD6649 Approved
0.701 Intermediate Similarity NPD8039 Approved
0.7009 Intermediate Similarity NPD6399 Phase 3
0.6984 Remote Similarity NPD7319 Approved
0.6983 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6972 Remote Similarity NPD4697 Phase 3
0.6957 Remote Similarity NPD6881 Approved
0.6957 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6957 Remote Similarity NPD6899 Approved
0.6937 Remote Similarity NPD6648 Approved
0.6923 Remote Similarity NPD5330 Approved
0.6923 Remote Similarity NPD7521 Approved
0.6923 Remote Similarity NPD6409 Approved
0.6923 Remote Similarity NPD7146 Approved
0.6923 Remote Similarity NPD6684 Approved
0.6923 Remote Similarity NPD7334 Approved
0.6916 Remote Similarity NPD6079 Approved
0.6916 Remote Similarity NPD7515 Phase 2
0.6897 Remote Similarity NPD6372 Approved
0.6897 Remote Similarity NPD6373 Approved
0.6885 Remote Similarity NPD6319 Approved
0.6881 Remote Similarity NPD1698 Clinical (unspecified phase)
0.688 Remote Similarity NPD7507 Approved
0.6875 Remote Similarity NPD7260 Phase 2
0.687 Remote Similarity NPD5697 Approved
0.6863 Remote Similarity NPD5209 Approved
0.6838 Remote Similarity NPD7290 Approved
0.6838 Remote Similarity NPD7102 Approved
0.6838 Remote Similarity NPD6883 Approved
0.6829 Remote Similarity NPD8517 Approved
0.6829 Remote Similarity NPD8516 Approved
0.6829 Remote Similarity NPD8513 Phase 3
0.6829 Remote Similarity NPD8515 Approved
0.6822 Remote Similarity NPD5785 Approved
0.6814 Remote Similarity NPD7632 Discontinued
0.681 Remote Similarity NPD6011 Approved
0.681 Remote Similarity NPD6686 Approved
0.6807 Remote Similarity NPD4632 Approved
0.68 Remote Similarity NPD7492 Approved
0.6792 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6792 Remote Similarity NPD6903 Approved
0.6792 Remote Similarity NPD5737 Approved
0.6792 Remote Similarity NPD6672 Approved
0.6783 Remote Similarity NPD5739 Approved
0.6783 Remote Similarity NPD6675 Approved
0.6783 Remote Similarity NPD6402 Approved
0.6783 Remote Similarity NPD7128 Approved
0.678 Remote Similarity NPD6847 Approved
0.678 Remote Similarity NPD6869 Approved
0.678 Remote Similarity NPD8130 Phase 1
0.678 Remote Similarity NPD6617 Approved
0.6759 Remote Similarity NPD7637 Suspended
0.6759 Remote Similarity NPD7983 Approved
0.6752 Remote Similarity NPD6014 Approved
0.6752 Remote Similarity NPD6013 Approved
0.6752 Remote Similarity NPD6012 Approved
0.6752 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6748 Remote Similarity NPD6054 Approved
0.6746 Remote Similarity NPD6616 Approved
0.6729 Remote Similarity NPD5328 Approved
0.6727 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6723 Remote Similarity NPD6882 Approved
0.6723 Remote Similarity NPD6053 Discontinued
0.6723 Remote Similarity NPD8297 Approved
0.672 Remote Similarity NPD8328 Phase 3
0.6696 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6693 Remote Similarity NPD7078 Approved
0.6667 Remote Similarity NPD5207 Approved
0.6667 Remote Similarity NPD7320 Approved
0.6667 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5222 Approved
0.6667 Remote Similarity NPD5221 Approved
0.6641 Remote Similarity NPD7736 Approved
0.664 Remote Similarity NPD6370 Approved
0.6639 Remote Similarity NPD6009 Approved
0.6607 Remote Similarity NPD5173 Approved
0.6606 Remote Similarity NPD6050 Approved
0.6606 Remote Similarity NPD5693 Phase 1
0.6606 Remote Similarity NPD5694 Approved
0.6604 Remote Similarity NPD3618 Phase 1
0.6587 Remote Similarity NPD7604 Phase 2
0.6581 Remote Similarity NPD5701 Approved
0.6579 Remote Similarity NPD5344 Discontinued
0.6562 Remote Similarity NPD8074 Phase 3
0.656 Remote Similarity NPD6015 Approved
0.656 Remote Similarity NPD5983 Phase 2
0.656 Remote Similarity NPD6016 Approved
0.6557 Remote Similarity NPD6868 Approved
0.6555 Remote Similarity NPD6371 Approved
0.6555 Remote Similarity NPD4634 Approved
0.6522 Remote Similarity NPD5211 Phase 2
0.6518 Remote Similarity NPD7839 Suspended
0.6514 Remote Similarity NPD6698 Approved
0.6514 Remote Similarity NPD46 Approved
0.6514 Remote Similarity NPD7838 Discovery
0.6514 Remote Similarity NPD5692 Phase 3
0.6509 Remote Similarity NPD1733 Clinical (unspecified phase)
0.6508 Remote Similarity NPD5988 Approved
0.6504 Remote Similarity NPD8295 Clinical (unspecified phase)
0.65 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6491 Remote Similarity NPD5285 Approved
0.6491 Remote Similarity NPD4696 Approved
0.6491 Remote Similarity NPD5286 Approved
0.6484 Remote Similarity NPD6336 Discontinued
0.648 Remote Similarity NPD6059 Approved
0.6455 Remote Similarity NPD8035 Phase 2
0.6455 Remote Similarity NPD5281 Approved
0.6455 Remote Similarity NPD5284 Approved
0.6455 Remote Similarity NPD8034 Phase 2
0.6452 Remote Similarity NPD6335 Approved
0.6449 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6449 Remote Similarity NPD5786 Approved
0.6441 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6439 Remote Similarity NPD6845 Suspended
0.6435 Remote Similarity NPD5223 Approved
0.6434 Remote Similarity NPD8293 Discontinued
0.6429 Remote Similarity NPD7503 Approved
0.6422 Remote Similarity NPD6673 Approved
0.6422 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6422 Remote Similarity NPD6051 Approved
0.6422 Remote Similarity NPD6904 Approved
0.6422 Remote Similarity NPD6080 Approved
0.641 Remote Similarity NPD5141 Approved
0.64 Remote Similarity NPD7100 Approved
0.64 Remote Similarity NPD7101 Approved
0.6379 Remote Similarity NPD4633 Approved
0.6379 Remote Similarity NPD5225 Approved
0.6379 Remote Similarity NPD5224 Approved
0.6379 Remote Similarity NPD5226 Approved
0.6371 Remote Similarity NPD6317 Approved
0.6355 Remote Similarity NPD5363 Approved
0.6339 Remote Similarity NPD5282 Discontinued
0.6339 Remote Similarity NPD6001 Approved
0.6333 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6325 Remote Similarity NPD5175 Approved
0.6325 Remote Similarity NPD5174 Approved
0.632 Remote Similarity NPD6314 Approved
0.632 Remote Similarity NPD6313 Approved
0.6316 Remote Similarity NPD6084 Phase 2
0.6316 Remote Similarity NPD4755 Approved
0.6316 Remote Similarity NPD6083 Phase 2
0.6299 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6299 Remote Similarity NPD6921 Approved
0.629 Remote Similarity NPD6274 Approved
0.6283 Remote Similarity NPD5695 Phase 3
0.6273 Remote Similarity NPD1695 Approved
0.6262 Remote Similarity NPD3668 Phase 3
0.6262 Remote Similarity NPD4786 Approved
0.6261 Remote Similarity NPD5696 Approved
0.6228 Remote Similarity NPD7732 Phase 3
0.6226 Remote Similarity NPD3667 Approved
0.6207 Remote Similarity NPD4700 Approved
0.619 Remote Similarity NPD8259 Clinical (unspecified phase)
0.619 Remote Similarity NPD4695 Discontinued
0.6182 Remote Similarity NPD5208 Approved
0.6167 Remote Similarity NPD6412 Phase 2
0.6147 Remote Similarity NPD6098 Approved
0.6147 Remote Similarity NPD5279 Phase 3
0.6146 Remote Similarity NPD5325 Clinical (unspecified phase)
0.614 Remote Similarity NPD5654 Approved
0.6136 Remote Similarity NPD6033 Approved
0.6131 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6116 Remote Similarity NPD5168 Approved
0.6116 Remote Similarity NPD4729 Approved
0.6116 Remote Similarity NPD4730 Approved
0.6111 Remote Similarity NPD3666 Approved
0.6111 Remote Similarity NPD3665 Phase 1
0.6111 Remote Similarity NPD3133 Approved
0.6107 Remote Similarity NPD8451 Approved
0.6106 Remote Similarity NPD4202 Approved
0.6087 Remote Similarity NPD6334 Approved
0.6087 Remote Similarity NPD6333 Approved
0.6078 Remote Similarity NPD4058 Approved
0.6077 Remote Similarity NPD7830 Approved
0.6077 Remote Similarity NPD7829 Approved
0.6075 Remote Similarity NPD4269 Approved
0.6075 Remote Similarity NPD4270 Approved
0.6068 Remote Similarity NPD6404 Discontinued
0.6063 Remote Similarity NPD7328 Approved
0.6063 Remote Similarity NPD7327 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data